Alterity Therapeutics Limited
Stock Forecast, Prediction & Price Target
Alterity Therapeutics Limited Financial Estimates
Alterity Therapeutics Limited Revenue Estimates
Alterity Therapeutics Limited EBITDA Estimates
Alterity Therapeutics Limited Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2026 | 6/30/2027 | ||
Revenue
% change YoY
| $3.53M N/A | $3.91M 10.71% | $4.01M 2.62% | Avg: $4.96M Low: $4.96M High: $4.96M avg. 23.61% | Avg: $755.93K Low: $755.93K High: $755.93K avg. -84.78% | ||
Net Income
% change YoY
| $-12.84M N/A | $-13.80M -7.46% | $-19.12M -38.51% | Avg: $-2.41B Low: $-2.41B High: $-2.41B avg. -12515.25% | Avg: $-176.00M Low: $-176.00M High: $-176.00M avg. 92.70% | ||
EBITDA
% change YoY
| $-17.80M N/A | $-17.51M 1.63% | $-19.57M -11.74% | Avg: $-4.96M Low: $-4.96M High: $-4.96M avg. 74.61% | Avg: $-755.93K Low: $-755.93K High: $-755.93K avg. 84.78% | ||
EPS
% change YoY
| -$0.01 N/A | -$0.01 -7.54% | -$0.01 8.77% | Avg: -$0.99 Low: -$0.99 High: -$0.99 avg. -19009.03% | Avg: -$0.07 Low: -$0.07 High: -$0.07 avg. 92.70% | ||
Operating Expenses
% change YoY
| $15.13M N/A | $17.34M 14.61% | $23.40M 34.91% | Avg: $52.73M Low: $52.73M High: $52.73M avg. 125.27% | Avg: $8.02M Low: $8.02M High: $8.02M avg. -84.78% | ||
FAQ
What is Alterity Therapeutics Limited stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -6211.27% in 2026-2027.
We have gathered data from N/A analysts. Their low estimate is -2.41B, average is -2.41B and high is -2.41B.
What is Alterity Therapeutics Limited stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of -30.58% in 2026-2027.
We have gathered data from N/A analysts. Their low revenue estimate is $4.96M, average is $4.96M and high is $4.96M.
What is Alterity Therapeutics Limited stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -9458.16% in 2026-2027.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.99, average is -$0.99 and high is $-0.99.